Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
75.40
-1.90 (-2.46%)
Apr 29, 2026, 1:30 PM CST

Gongwin Biopharm Holdings Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
968.9893.47273.59671.51454.12
Upgrade
Short-Term Investments
234.3848.99668.66434.1372.2
Upgrade
Trading Asset Securities
463.03466.79---
Upgrade
Cash & Short-Term Investments
1,6662,209942.251,106826.33
Upgrade
Cash Growth
-24.58%134.47%-14.78%33.80%-20.45%
Upgrade
Accounts Receivable
16.5314.1710.58--
Upgrade
Other Receivables
8.3512.314.524.250.06
Upgrade
Receivables
24.8726.4815.14.250.06
Upgrade
Inventory
0.893.5911.930.21-
Upgrade
Prepaid Expenses
18.6212.8911.3611.11-
Upgrade
Other Current Assets
157.82180.62138.42215.8893.74
Upgrade
Total Current Assets
1,8682,4331,1191,337920.12
Upgrade
Property, Plant & Equipment
320.85330.89118.32245.05246.76
Upgrade
Long-Term Investments
487.24497.81156.6132.353.88
Upgrade
Other Intangible Assets
0.830.370.19--
Upgrade
Other Long-Term Assets
119.68120.3121.177.471.12
Upgrade
Total Assets
2,7973,3821,5151,6221,172
Upgrade
Accounts Payable
0.130.210.29--
Upgrade
Accrued Expenses
38.428.8126.3732.6321.97
Upgrade
Short-Term Debt
117.37110.6375.02134.55113.06
Upgrade
Current Portion of Leases
3.123.212.125.011.99
Upgrade
Current Income Taxes Payable
15.8715.715.1315.4415.2
Upgrade
Other Current Liabilities
5.5323.67.443.622.54
Upgrade
Total Current Liabilities
180.42182.16126.36191.26154.75
Upgrade
Long-Term Leases
9.2512.910.032.180.1
Upgrade
Long-Term Unearned Revenue
50.4145.0145.0842.0329.57
Upgrade
Other Long-Term Liabilities
39.1241.7632.0613.240
Upgrade
Total Liabilities
279.2281.84203.53248.7184.43
Upgrade
Common Stock
1,2751,2751,1331,1311,099
Upgrade
Additional Paid-In Capital
3,5003,5001,6441,6341,061
Upgrade
Retained Earnings
-1,646-1,529-1,441-1,349-1,094
Upgrade
Treasury Stock
-532.98-166.61---
Upgrade
Comprehensive Income & Other
-64.8827.14-21.35-24.77-95.34
Upgrade
Total Common Equity
2,5313,1071,3151,392970.72
Upgrade
Minority Interest
-13.11-6.2-3.68-18.5816.74
Upgrade
Shareholders' Equity
2,5183,1001,3121,373987.45
Upgrade
Total Liabilities & Equity
2,7973,3821,5151,6221,172
Upgrade
Total Debt
129.74126.7577.17141.74115.14
Upgrade
Net Cash (Debt)
1,5362,082865.08963.87711.19
Upgrade
Net Cash Growth
-26.22%140.73%-10.25%35.53%-29.07%
Upgrade
Net Cash Per Share
12.4517.247.648.676.49
Upgrade
Filing Date Shares Outstanding
122.62126.06113.34113.09109.92
Upgrade
Total Common Shares Outstanding
122.62126.06113.34113.09109.92
Upgrade
Working Capital
1,6882,251992.71,146765.37
Upgrade
Book Value Per Share
20.6424.6411.6112.318.83
Upgrade
Tangible Book Value
2,5303,1061,3151,392970.72
Upgrade
Tangible Book Value Per Share
20.6324.6411.6112.318.83
Upgrade
Land
228.65228.6549.69155155
Upgrade
Buildings
76.2275.2952.9569.5969.23
Upgrade
Machinery
62.6262.6663.4356.7654.91
Upgrade
Construction In Progress
----0.54
Upgrade
Leasehold Improvements
10.9911.33.753.753.75
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.